Xeris Biopharma Holdings, Inc.
XERS
$7.59
$0.020.26%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
8/21/2025
-
MarketBeat
8/18/2025
-
MarketBeat
8/17/2025
-
MarketBeat
8/17/2025
-
Simply Wall St
8/16/2025
-
MarketBeat
8/15/2025
-
GuruFocus
8/15/2025
-
MarketBeat
8/15/2025
-
Simply Wall St
8/15/2025
-
MarketBeat
8/13/2025
-
MarketBeat
8/13/2025
-
Simply Wall St
8/12/2025
-
Zacks Investment Research
8/12/2025
-
Zacks Investment Research
8/12/2025
-
MarketBeat
8/11/2025
-
MarketBeat
8/10/2025
-
Simply Wall St
8/10/2025
-
MarketBeat
8/9/2025
-
MarketBeat
8/8/2025
-
MarketBeat
8/8/2025
-
Tickeron - Stocks
8/8/2025
-
Tickeron - Stocks
8/8/2025
-
GuruFocus
8/8/2025
-
GuruFocus
8/8/2025
-
GuruFocus
8/7/2025
-
Seeking Alpha: Transcripts
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
844 445 5704
Address
1375 West Fulton Street
Chicago, IL 60607
Chicago, IL 60607
Country
Year Founded
Business Description
Sector
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The...
more